1. Home
  2. ENVB vs AMIX Comparison

ENVB vs AMIX Comparison

Compare ENVB & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVB
  • AMIX
  • Stock Information
  • Founded
  • ENVB 1994
  • AMIX 2014
  • Country
  • ENVB United States
  • AMIX United States
  • Employees
  • ENVB N/A
  • AMIX N/A
  • Industry
  • ENVB Biotechnology: Pharmaceutical Preparations
  • AMIX
  • Sector
  • ENVB Health Care
  • AMIX
  • Exchange
  • ENVB Nasdaq
  • AMIX NYSE
  • Market Cap
  • ENVB 3.1M
  • AMIX 3.5M
  • IPO Year
  • ENVB N/A
  • AMIX N/A
  • Fundamental
  • Price
  • ENVB $1.27
  • AMIX $1.28
  • Analyst Decision
  • ENVB Strong Buy
  • AMIX Strong Buy
  • Analyst Count
  • ENVB 1
  • AMIX 1
  • Target Price
  • ENVB $10.00
  • AMIX $5.00
  • AVG Volume (30 Days)
  • ENVB 225.8K
  • AMIX 287.4K
  • Earning Date
  • ENVB 08-11-2025
  • AMIX 08-12-2025
  • Dividend Yield
  • ENVB N/A
  • AMIX N/A
  • EPS Growth
  • ENVB N/A
  • AMIX N/A
  • EPS
  • ENVB N/A
  • AMIX N/A
  • Revenue
  • ENVB N/A
  • AMIX N/A
  • Revenue This Year
  • ENVB N/A
  • AMIX N/A
  • Revenue Next Year
  • ENVB N/A
  • AMIX N/A
  • P/E Ratio
  • ENVB N/A
  • AMIX N/A
  • Revenue Growth
  • ENVB N/A
  • AMIX N/A
  • 52 Week Low
  • ENVB $1.01
  • AMIX $1.14
  • 52 Week High
  • ENVB $11.55
  • AMIX $42.40
  • Technical
  • Relative Strength Index (RSI)
  • ENVB 46.13
  • AMIX 34.92
  • Support Level
  • ENVB $1.18
  • AMIX $1.14
  • Resistance Level
  • ENVB $1.30
  • AMIX $1.36
  • Average True Range (ATR)
  • ENVB 0.07
  • AMIX 0.11
  • MACD
  • ENVB 0.02
  • AMIX -0.02
  • Stochastic Oscillator
  • ENVB 50.00
  • AMIX 25.00

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

About AMIX AUTONOMIX MEDICAL INC

Autonomix Medical Inc is a development-stage medical device development company focused on advancing technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.

Share on Social Networks: